Ever/Body opened its first location in New York City in 2019, pioneering a first-of-its-kind approach to cosmetic dermatology that combines an unparalleled industry standard of medical expertise with a convenient and modern client experience. Ever/Body leverages its proprietary technology platform to create a seamless and personalized client journey, from appointment scheduling to pre- and post-treatment care. Ever/Body is also leading the category with its best-in-class provider education program, which ensures that providers are able to treat a diverse range of clientele, including all ages, skin tones, body types, and genders. The company, part of the Redesign Health portfolio, is led by CEO Amy Shecter and features a predominantly female leadership team.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/09/22 | $55,500,000 | Series C |
ACME Capital ADDITION  Declaration Capital Fifth Wall Ventures Imaginary Ventures Redesign Health Tiger Global Management | undisclosed |
